Today: 27 June 2026
Palantir stock price today: PLTR wobbles in premarket as Airbus deal and analyst upgrade hit the tape
12 February 2026
2 mins read

Palantir stock price today: PLTR wobbles in premarket as Airbus deal and analyst upgrade hit the tape

New York, Feb 12, 2026, 07:37 EST — Premarket

  • Palantir shares dipped a bit before the bell, coming off a 2.75% drop from the previous session.
  • The company has extended its multi-year strategic partnership with Airbus, it said.
  • Friday’s U.S. inflation numbers have traders on watch. Software stocks with hefty price tags remain quick to react to any shifts in AI sentiment.

Palantir Technologies (PLTR.O) edged down 0.13% to $135.50 early Thursday, following a 2.75% slide to $135.68 at Wednesday’s close.

That modest shift hides a tougher reality for bulls. Palantir’s turned into a weathervane for the “AI software” crowd, where sentiment can turn on a dime. A contract update, a guidance nudge—sometimes just a single broker’s take—and the stock can lurch, especially when trading’s thin.

The distinction has become critical as investors sift through AI buzz versus real, lasting demand. Palantir’s right in that crossroads — pitching software that embeds itself inside major enterprises and government agencies. Still, its lofty valuation doesn’t offer much forgiveness if things go sideways.

Palantir announced it’s extending its work with Airbus, locking in a multi-year deal that keeps the data analytics firm behind the Skywise open-data platform for civil aviation. According to Palantir, Skywise now serves over 50,000 users. The company highlighted its push to support “sovereign cloud” architectures—keeping sensitive data within borders—and pointed to the platform’s use of multiple large language models, the backbone of chat-style AI. Business Wire

Wall Street’s still hashing out how to value that growth. Daiwa Capital Markets bumped Palantir up to “Buy” from “Hold,” but dropped its price target to $180 from $200. The firm described the company’s latest quarter as leaving a “positive impression” and flagged what it called “extraordinary demand” for Palantir’s Artificial Intelligence Platform (AIP). TipRanks

It’s a tricky setup. According to JPMorgan strategists, the latest slide in software stocks has already baked in some of the bleakest potential fallout from AI disruption. Morgan Stanley’s Katy Huberty, meanwhile, sees the valuation gap as driven more by market mood than any change in company fundamentals, with investors rethinking positions in software names after the recent AI-driven rout.

Palantir’s most recent report shifted expectations and reignited debate over its valuation. U.S. government revenue jumped 66% in the fourth quarter, hitting $570 million and driving total sales to $1.41 billion. Even after shares slipped earlier this year, Reuters noted they were still changing hands at roughly 131 times forward earnings.

Still, there’s a snag: Airbus didn’t release any financial details, and just stacking up contract announcements rarely brings immediate profit. Hotter-than-forecast inflation, a spike in bond yields—those can quickly sap appetite for pricey growth names. Palantir, in particular, has taken its share of hits when the mood shifts.

Next up on traders’ radar: the U.S. January Consumer Price Index, dropping Friday at 8:30 a.m. ET. It’s a number with the potential to jolt rate bets and shake up tech sentiment for the coming week.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop